identifeye HEALTH

identifeye HEALTH

AI-driven retinal imaging diagnostics platform

Overview

Identifeye Health provides an AI-powered retinal imaging platform that helps clinics and hospitals capture and analyze eye images in real time. The system uses an imaging device to collect retinal data, an AI analysis layer to identify biomarkers and risk indicators, and a clinician-facing interface for results and recommendations, allowing non-specialists to operate the workflow. It differentiates itself by enabling point-of-care retinal diagnostics for non-experts and by offering ongoing AI algorithm updates and support as a service to healthcare institutions. The goal is to broaden access to accurate retinal assessments, supporting earlier disease detection and better patient outcomes through streamlined workflows and real-time decision support.

Significant Headcount Growth

About identifeye HEALTH

Simplify's Rating
Why identifeye HEALTH is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Series B

Total Funding

$80M

Headquarters

Guilford, Connecticut

Founded

2018

Get referred to identifeye HEALTH

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • identifeye HEALTH launched commercial retinal screening in August 2025 and now delivers patient results.
  • The company raised $90 million in 2025, funding manufacturing and sales expansion.
  • Current pilots with health systems and community providers create a near-term conversion pipeline.

What critics are saying

  • The AI screening algorithm still needs separate FDA clearance, delaying premium claims.
  • Pilot-heavy distribution with RAM Ohio and Dare to C.A.R.E. limits revenue visibility.
  • Without reimbursement and broad health-system adoption, the platform becomes a niche device business.

What makes identifeye HEALTH unique

  • FDA-registered, app-based retinal screening reaches patients outside specialist offices.
  • Combines retinal modalities, expert annotations, and AI for immediate point-of-care assessment.
  • 4Catalyzer backing and experienced commercialization leadership support execution speed.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$80M

Above

Industry Average

Funded Over

1 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$65M
Substack
$80M
identifeye HEALTH
$100M
ClickUp

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Hybrid Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-5%

1 year growth

6%

2 year growth

6%
Cardiac Vascular News
Apr 29th, 2022
Tesseract Health hires Michael McConnell as Head of Cardiovascular and Digital Health

Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract’s Head of Cardiovascular and Digital Health.

Business Wire
Apr 20th, 2021
Tesseract Health Closes Oversubscribed $80 Million Series B Financing

GUILFORD, Conn.--(BUSINESS WIRE)--Tesseract Health Inc. has raised $80 million in an oversubscribed Series B financing round.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for identifeye HEALTH right now.

Find jobs on Simplify and start your career today

We update identifeye HEALTH's jobs every few hours, so check again soon! Browse all jobs →